Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Sees Significant Decline in Short Interest

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totaling 2,031,410 shares, a drop of 45.7% from the April 30th total of 3,744,107 shares. Based on an average daily trading volume, of 3,636 shares, the short-interest ratio is presently 558.7 days.

Genomma Lab Internacional Stock Performance

GNMLF stock remained flat at $1.08 during midday trading on Tuesday. Genomma Lab Internacional has a 52 week low of $0.91 and a 52 week high of $1.27. The business has a fifty day moving average price of $1.04 and a two-hundred day moving average price of $1.02.

About Genomma Lab Internacional

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.